관상동맥 성형술 시장 규모, 점유율 및 성장 분석 : 시술 유형별, 디바이스 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Coronary Angioplasty Market size was valued at USD 897.9 Million in 2024 and is poised to grow from USD 967.94 Million in 2025 to USD 1765.21 Million by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The global coronary angioplasty market is significantly influenced by the increasing prevalence of ischemic heart disease, primarily driven by aging populations and lifestyle factors such as diabetes, hypertension, and obesity. This minimally invasive procedure, which involves balloon dilation and stent placement, plays a crucial role in lowering mortality, reducing hospital stays, and facilitating faster patient recovery. Technological advancements, including the evolution from conventional balloons to drug-eluting stents and enhanced imaging techniques, have considerably improved patient outcomes. Moreover, the integration of AI in clinical settings enhances diagnosis and procedural planning, enabling more precise interventions. As emerging markets witness expanded cardiovascular screenings and established regions embrace radial access methods, a favorable demand landscape develops, benefiting device manufacturers, healthcare providers, and patients alike.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Coronary Angioplasty market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Coronary Angioplasty Market Segments Analysis

Global coronary angioplasty market is segmented by procedure type, device type, end user and region. Based on procedure type, the market is segmented into Percutaneous Coronary and Coronary Artery Bypass. Based on device type, the market is segmented into Stents and Angioplasty Balloons. Based on end user, the market is segmented into Hospitals, Cardiac Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Coronary Angioplasty Market

The rising incidence of cardiovascular diseases significantly amplifies the number of patients in need of interventional treatments, subsequently driving the demand for coronary angioplasty procedures and associated devices. As physicians encounter more patients with ischemic conditions, there is an increasing preference for minimally invasive percutaneous techniques, which facilitate quicker recovery times and precise lesion targeting. This trend encourages healthcare facilities to enhance their catheterization lab resources and device inventories. Additionally, heightened awareness among both healthcare providers and patients regarding the advantages of these treatments further boosts the adoption rates, contributing to the continuous growth of the market and reinforcing the demand for these essential procedures.

Restraints in the Global Coronary Angioplasty Market

The global coronary angioplasty market faces several constraints mainly due to the high costs linked to procedures and advanced devices, which hinder widespread access and adoption. Insufficient reimbursement policies and tight institutional budgets exacerbate these challenges, as healthcare providers become more cautious in upgrading or expanding their services. The substantial capital investment required for catheterization labs, coupled with ongoing costs for specialized consumables, further complicates matters, especially in resource-limited environments. Additionally, concerns about patient affordability lead to reduced uptake of procedures when out-of-pocket costs are burdensome, ultimately prompting stakeholders to focus on cost containment rather than the swift acquisition of innovative technologies.

Market Trends of the Global Coronary Angioplasty Market

The Global Coronary Angioplasty market is experiencing a significant trend towards the integration of imaging and physiological assessments within intraprocedural workflows. This convergence allows for enhanced visualization and more precise lesion characterization, empowering practitioners to make informed decisions that tailor interventions to individual patient needs. As vendors develop interoperable platforms that merge imaging and flow data, the emphasis on multimodality interpretation is reinforced through specialized training programs. This seamless integration fosters precision interventions, drives evidence generation in real-world scenarios, and ultimately strengthens the case for adopting advanced angioplasty solutions, leading to improved patient outcomes and increased institutional acceptance.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Coronary Angioplasty Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Percutaneous Coronary
  • Balloon Angioplasty
  • Stent Placement
• Coronary Artery Bypass

Global Coronary Angioplasty Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Stents
  • Drug-Eluting Stents
  • Bare-Metal Stents
• Angioplasty Balloons
  • Standard Balloons
  • Scoring Balloons

Global Coronary Angioplasty Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Clinics
• Others

Global Coronary Angioplasty Market Size & CAGR (2026-2033)

• North America (Procedure Type, Device Type, End User)
  • US
  • Canada
• Europe (Procedure Type, Device Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Procedure Type, Device Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Procedure Type, Device Type, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Procedure Type, Device Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiovascular Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anthos Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saranas, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gore Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic's Miniature Coronary Intervention
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations